165
Views
2
CrossRef citations to date
0
Altmetric
Original Article

Agreement between the ‘point of care’ tests for microalbuminuria and HbA1c performed in mexican family medicine units and the results of standard laboratory tests

, , , , , , , , , & ORCID Icon show all
Pages 87-93 | Received 05 Jul 2017, Accepted 10 Dec 2017, Published online: 15 Dec 2017

References

  • American Diabetes Association. Standards of Medical Care in Diabetes-2017: Summary of Revisions. Diabetes Care. 2017; 40(Suppl 1):S1–S135.
  • Available at: https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/MedicalDevices/MedicalDevicesAdvisoryCommittee/ClinicalChemistryandClinicalToxicologyDevicesPanel/UCM511599.pdf. Accessed May 3, 2017.
  • Oellgaard J, Gaede P, Rossing P, et al. Intensified multifactorial intervention in type 2 diabetics with microalbuminuria leads to long-term renal benefits. Kidney Int. 2017; 91:982–988.
  • Bello AK, Levin A, Tonelli M, et al. Assessment of Global Kidney Health Care Status. JAMA. 2017;317:1864–1868.
  • Nathan D, Kuenen J, Borg R, A1c-Derived Average Glucose Study Group, et al. Translating the A1C assay into estimated average glucose values. Diabetes Care. 2008;31:1473–1478.
  • Stults B, Jones R. Management of hypertension in diabetes. Diabetes Spectr. 2006;19:25–31.
  • American Diabetes Association. Standards of Medical Care in Diabetes-2014. Diabetes Care. 2014;37(Suppl1):S14–S80.
  • National Committee for Quality Assurance. HEDIS 2009 Technical Specifications. Available at: http://www.ncqa.org/Portals/0/HomePage/Compiled_PC_Materials.pdf. Accessed May 2, 2017.
  • Qaseem A, Vijan S, Snow V, Clinical Efficacy Assessment Subcommittee of the American College of Physicians, et al. Glycemic control and type 2 diabetes mellitus: the optimal hemoglobin A1c targets. A guidance statement from the American College of Physicians. Ann Intern Med. 2007;147:417–422.
  • Wiwanitkit V. Analysis on weight-turnaround time properties for point-of-care testing tool for microalbumin determination: implication for using in distanced site. Ren Fail. 2010;32:533–534.
  • Miller C, Barnes C, Phillips L, et al. Rapid A1c availability improves clinical decision-making in an urban primary care clinic. Diabetes Care. 2003;26:1158–1163.
  • Thaler L, Ziemer D, Gallina D, et al. Diabetes in urban African-Americans. XVII. Availability of rapid HbA1c measurements enhances clinical decision-making. Diabetes Care. 1999;22:1415–1421.
  • Kost G, Kanoksilp A, Mecozzi D, et al. Point-of-need hemoglobin A1c for evidence-based diabetes care in rural small-world networks Khumuang Community Hospital, Buriram, Thailand. Point of Care. 2011;10:28–33.
  • Lenters-Westra E, Slingerland RJ. Six of eight hemoglobin A1c point-of-care instruments do not meet the general accepted analytical performance criteria. Clin Chem. 2010;56:44–52.
  • Lenters-Westra E, Slingerland R. Three of 7 hemoglobin A1c point-of-care instruments do not meet generally accepted analytical performance criteria. Clin Chem. 2014;60:1062–1072.
  • Food and Drug Administration, USA. 2007 approval of the DCA VantageTM. Available at: https://www.accessdata.fda.gov/cdrh_docs/pdf7/K071466.pdf [cited 2017 Mar 10].
  • Levey AS, Bosch JP, Lewis JB, et al. A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Ann Intern Med. 1999;130:461–470.
  • Perkovic V, Agarwal R, Fioretto P, Conference Participants, et al. Management of patients with diabetes and CKD: conclusions from a “Kidney Disease: Improving Global Outcomes” (KDIGO) Controversies Conference. Kidney Int. 2016;90:1175–1183.
  • O'Brien E, Asmar R, Beilin L, et al. European Society of Hypertension Working Group on Blood Pressure Monitoring. Practice guidelines of the European Society of Hypertension for clinic, ambulatory and self-blood pressure measurement. J Hypertens. 2005;23:697–701.
  • Cohen J. A coefficient of agreement for nominal scales. Educ Psychol Meas. 1960;20:37–46.
  • Mundet Tudurí X, Martínez Carmona S, Espinosa Gonzalez N, et al. Utilidad del cociente albúmina/creatinina en el diagnóstico de la nefropatía en pacientes con diabetes mellitus tipo 2. Med Clin (Barc). 2001;116:732–733.
  • Ewald B, Attia J. Which test to detect microalbuminuria in diabetic patients? A systematic review. Aust Fam Physician. 2004;33:565–568.
  • Ng WY, Lui KF, Thai AC. Evaluation of a rapid screening test for microalbuminuria with a spot measurement of urine albumin-creatinine ratio. Ann Acad Med Singapore. 2000;29:62–65.
  • KDOQI Clinical Practice Guidelines and Clinical Practice Recommendations for Diabetes and Chronic Kidney Disease. Am J Kidney Dis. 2007;49(Suppl 2):S1–S180.
  • Bermejo S, Pascual J, Soler MJ. The large spectrum of renal disease in diabetic patients. Clin Kidney J. 2017;10:255–256.
  • Mash R, Ugoagwu A, Vos C, et al. Evaluating point-of-care testing for glycosylated haemoglobin in public sector primary care facilities in the Western Cape, South Africa. S Afr Med J. 2016;106:1236–1240.
  • NOMESCO report on Health Statistics in the Nordic countries, Copenhagen, 2015.
  • Paknikar S, Sarmah R, Sivaganeshan L, et al. Long-Term Performance of Point-of-Care Hemoglobin A1c Assays. J Diabetes Sci Technol. 2016;10:1308–1315.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.